ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2018.06.066
PubMed Identifier: 30021161
Publication URI: http://europepmc.org/abstract/MED/30021161
Type: Journal Article/Review
Volume: 24
Parent Publication: Cell reports
Issue: 3